JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB273521

Ispinesib (SB-715992)

Be the first to review this product! Submit a review

|

(4 Publications)

MW 517.1 Da, Purity >98%. A potent, selective and reversible allosteric inhibitor of KSP with IC50 value of 0.5 nM. Often combines with chemotherapy drugs to tumor treatment.
1 Images
Chemical Structure - Ispinesib (SB-715992) (AB273521)
  • Chemical Structure

Lab

Chemical Structure - Ispinesib (SB-715992) (AB273521)

Chemical structure of Ispinesib (SB-715992), 336113-53-2

Key facts

CAS number

336113-53-2

Purity

>98%

Form

Solid

form

Molecular weight

517.1 Da

Molecular formula

C<sub>3</sub><sub>0</sub>H<sub>3</sub><sub>3</sub>ClN<sub>4</sub>O<sub>2</sub>

PubChem

6851740

Nature

Synthetic

Solubility

Soluble in DMSO to 50 mM

Soluble in ethanol to 100 mM

Biochemical name

Ispinesib

Biological description

A potent, selective and reversible allosteric inhibitor of KSP with IC50 value of 0.5 nM. Often combines with chemotherapy drugs to tumor treatment.

Canonical smiles

CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C

Isomeric smiles

CC1=CC=C(C=C1)C(=O)N(CCCN)[C@@H](C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C

InChi

InChI=1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1

InChiKey

QJZRFPJCWMNVAV-HHHXNRCGSA-N

IUPAC Name

N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Clinical cancer research : an official journal of 16:566-76 PubMed20068098

2010

Activity of the kinesin spindle protein inhibitor ispinesib (SB-715992) in models of breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

James W Purcell,Jefferson Davis,Mamatha Reddy,Shamra Martin,Kimberly Samayoa,Hung Vo,Karen Thomsen,Peter Bean,Wen Lin Kuo,Safiyyah Ziyad,Jessica Billig,Heidi S Feiler,Joe W Gray,Kenneth W Wood,Sylvaine Cases

Pediatric blood & cancer 53:1255-63 PubMed19554570

2009

Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.

Applications

Unspecified application

Species

Unspecified reactive species

Hernan Carol,Richard Lock,Peter J Houghton,Christopher L Morton,E Anders Kolb,Richard Gorlick,C Patrick Reynolds,John M Maris,Stephen T Keir,Catherine A Billups,Malcolm A Smith

Biochemistry 47:3576-85 PubMed18290633

2008

Mechanism of inhibition of human KSP by ispinesib.

Applications

Unspecified application

Species

Unspecified reactive species

Latesh Lad,Lusong Luo,Jeffrey D Carson,Kenneth W Wood,James J Hartman,Robert A Copeland,Roman Sakowicz

BMC cancer 6:22 PubMed16433906

2006

Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line.

Applications

Unspecified application

Species

Unspecified reactive species

David A Davis,Sarah H Sarkar,Maha Hussain,Yiwei Li,Fazlul H Sarkar
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com